Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 206.36

+1.4%

Nov 26 3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Hippieslayer who wrote (21541)	5/29/1998 7:17:00 AM
From: Henry Niman	Read Replies (1) of 32384

Reuter's also carried the NDA news: Wednesday May 27, 9:34 pm Eastern Time Ligand applies for Panretin approval SAN DIEGO, May 27 (Reuters) - Ligand Pharmaceuticals Inc on Wednesday said it has submitted its first new drug application to the U.S. Food and Drug Administration for Panretin gel, or alitretinoin, used to help treat patients with AIDS-related Kaposi's sarcoma. If approved, Panretin gel would provide the first topical therapy for Kaposi's Sarcoma, a cancer common in people who have AIDS, the company said in a statement.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next